BIOWKS logo

Bio-Works Technologies AB (publ) Stock Price

NGM:BIOWKS Community·SEK 359.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BIOWKS Share Price Performance

SEK 3.62
2.54 (236.74%)
SEK 3.62
2.54 (236.74%)
Price SEK 3.62

BIOWKS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

Bio-Works Technologies AB (publ) Key Details

SEK 63.1m

Revenue

SEK 14.7m

Cost of Revenue

SEK 48.4m

Gross Profit

SEK 63.7m

Other Expenses

-SEK 15.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.15
76.71%
-24.16%
0%
View Full Analysis

About BIOWKS

Founded
2006
Employees
26
CEO
Lone Carlbom
WebsiteView website
www.bio-works.com

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography resins. Its products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Recent BIOWKS News & Updates

Will Bio-Works Technologies (NGM:BIOWKS) Spend Its Cash Wisely?

Dec 03
Will Bio-Works Technologies (NGM:BIOWKS) Spend Its Cash Wisely?

Recent updates

No updates